The trial included 614 patients with severe heart failure in the United States and Canada. They were randomly assigned to receive either the MitraClip plus standard therapy or standard therapy alone.
from WebMD Health https://ift.tt/2pyVwUs
via IFTTT
No comments:
Post a Comment